The Vice President will lead Umoja Biopharma’s enterprise portfolio and program management strategy, aligning drug development programs with corporate priorities, resources, milestones, risks, and commercialization goals. Responsibilities include establishing the portfolio management function, guiding prioritization and governance, developing integrated plans and dashboards, managing risks and capacity, supporting executive and board decisions, and building a high-performing program leadership team. The role also contributes to annual operating plans, long-range strategy, organizational scaling, and cross-functional execution across research, clinical, technical, regulatory, quality, medical, and finance functions.

Lead securities and corporate governance counsel driving IPO readiness, SEC reporting, disclosure controls, and public company compliance. Advise CLO, CEO, CFO, Board and executives; prepare S-1 and other registration and disclosure filings; manage disclosure committee, governance documents, insider trading programs, and public financings; coordinate with external counsel, auditors, bankers, and investors.